Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IMAGO BIOSCIENCES, INC.

(IMGO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/02/2021 12/03/2021 12/06/2021 12/07/2021 12/08/2021 Date
22.61(c) 20.43(c) 16.22(c) 17.8(c) 18.98(c) Last
169 174 153 841 349 530 336 283 179 674 Volume
+2.12% -9.64% -20.61% +9.74% +6.63% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -40,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 -8,37x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -57,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -11,5x
Yield 2022 -
Capitalization 636 M 636 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 20
Free-Float 95,4%
More Financials
Company
Imago Biosciences, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. It focuses on providing treatment for patients with cancer and bone marrow diseases. Its lead product candidate is... 
Sector
Biotechnology & Medical Research
Calendar
12/11 | 12:00pmPresentation
More about the company
All news about IMAGO BIOSCIENCES, INC.
12/01Imago BioSciences to Host Virtual Investor Event
AQ
11/19IMAGO BIOSCIENCES : Appoints Laurie Keating to Board of Directors - Form 8-K
PU
11/19IMAGO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Regulation FD Disclos..
AQ
11/18Imago BioSciences Appoints Laurie Keating to Board of Directors
BU
11/18Imago Biosciences Appoints Laurie Keating to Board of Directors
CI
11/11Imago BioSciences to Present at Stifel 2021 Virtual Healthcare Conference
AQ
11/10IMAGO BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
11/10Imago BioSciences Reports Third Quarter 2021 Financial Results and Provides Recent Busi..
PU
11/10Imago BioSciences Reports Third Quarter 2021 Financial Results and Provides Recent Busi..
AQ
11/04Imago BioSciences Announces Oral Data Presentations at the Upcoming 63rd American Socie..
BU
09/30IMAGO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/30Imago BioSciences, Inc. Appoints Laura Eichorn as Operations Officer and the Principal ..
CI
09/30Imago BioSciences, Inc. Announces Executive Changes
CI
09/20IMAGO BIOSCIENCES : Announces Its Addition to the Russell 2000® Index
BU
09/20IMAGO BIOSCIENCES, INC.(NASDAQGS : IMGO) added to S&P TMI Index
CI
More news
News in other languages on IMAGO BIOSCIENCES, INC.
08/19La perte d'Imago BioSciences au deuxième trimestre se creuse par rapport à l'année préc..
08/10HOY EN WALL STREET : Surgen nuevas pistas sobre el calendario del tapering
07/30Imago BioSciences obtient la désignation orpheline de l'Agence européenne des médicamen..
07/16Imago Biosciences ouvre en hausse au Nasdaq après avoir fixé le prix de son introductio..
More news
Analyst Recommendations on IMAGO BIOSCIENCES, INC.
More recommendations
Chart IMAGO BIOSCIENCES, INC.
Duration : Period :
Imago BioSciences, Inc. Technical Analysis Chart | IMGO | US45250K1079 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 18,98 $
Average target price 33,00 $
Spread / Average Target 73,9%
EPS Revisions
Managers and Directors
Hugh Young Rienhoff Chief Executive Officer & Director
Laura G. Eichorn Chief Operating, Financial & Accounting Officer
Dennis J. Henner Chairman
Jennifer Peppe Senior Vice President-Clinical Operations
Wan-Jen Hong Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
IMAGO BIOSCIENCES, INC.0.00%636
MODERNA, INC.171.27%114 904
LONZA GROUP AG30.52%59 816
IQVIA HOLDINGS INC.51.92%51 999
SEAGEN INC.-14.61%27 346
CELLTRION, INC.-42.20%24 169